Anti-fibrotic effect of FGF21 in pulmonary fibrosis

被引：0

作者：

Ghanem, Mada ^{[1
]}

Archer, Gabrielle ^{[1
]}

Justet, Aurelien ^{[1
]}

Hachem, Mouna ^{[1
]}

Boghanim, Tiara ^{[1
]}

Vadel, Aurelie ^{[1
]}

Pote, Nicolas ^{[1
]}

Cazes, Aurelie ^{[1
]}

Mordant, Pierre ^{[1
]}

Castier, Yves ^{[1
]}

Mal, Herve ^{[1
]}

Jaillet, Madeleine ^{[1
]}

Mailleux, Arnaud ^{[1
]}

Crestani, Bruno ^{[1
]}

机构：

[1] INSERM, Paris, France

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

D O I：

10.1183/13993003.congress-2023.PA1230

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：2

共 50 条

[1] Involvement of FGF21 in pulmonary fibrosis
Ghanem, M.
Justet, A.
Hachem, M.
Boghanim, T.
Vadel, A.
Jaillet, M.
Mailleux, A.
Crestani, B.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[2] Involvement of FGF21 in Pulmonary Fibrosis
Ghanem, M.
Justet, A.
Hachem, M.
Boghanim, T.
Vadel, A.
Jaillet, M.
Mailleux, A.
Crestani, B.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[3] Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast-to-myofibroblast transition
Lin, Haobo
Wu, Chaochen
Zhu, Fu
Zhang, Guangfeng
Xie, Yuesheng
Cui, Yang
Dong, Guangfu
Zhang, Xiao
[J]. ADVANCES IN MEDICAL SCIENCES, 2020, 65 (02): : 338 - 347
[4] Anti-fibrotic effect of black tea (Camellia sinensis) extract in experimental pulmonary fibrosis
Chakraborty, Kaustav
Dey, Avijit
Bhattacharyya, Arindam
Dasgupta, Subir Chandra
[J]. TISSUE & CELL, 2019, 56 : 14 - 22
[5] The efficacy of anti-fibrotic agents for acute exacerbation of idiopathic pulmonary fibrosis
Matsumoto, Yoko
Furukawa, Ryutaro
Ohara, Sayaka
Usui, Kazuhiro
[J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
[6] Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis
Nakahara, Yoshio
Hashimoto, Naozumi
Sakamoto, Koji
Enomoto, Atsushi
Adams, Taylor S.
Yokoi, Toyoharu
Omote, Norihito
Poli, Sergio
Ando, Akira
Wakahara, Keiko
Suzuki, Atsushi
Inoue, Masahide
Hara, Akitoshi
Mizutani, Yasuyuki
Imaizumi, Kazuyoshi
Kawabe, Tsutomu
Rosas, Ivan O.
Takahashi, Masahide
Kaminski, Naftali
Hasegawa, Yoshinori
[J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58 (06)
[7] Anti-fibrotic role of inhaled interferon-γ in idiopathic pulmonary fibrosis
Hasaneen, Nadia
Tuong Vu
Fusiak, Timothy
Foda, Hussein
Condos, Rany
Smaldone, Gerald
[J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
[8] Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications
Nair, Girish B.
Matela, Ajsza
Kurbanov, Daniel
Raghu, Ganesh
[J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (06) : 699 - 711
[9] Anti-Fibrotic Therapy and Patient Reported Outcomes in Idiopathic Pulmonary Fibrosis
Kay, S.
White, E. S.
Sheth, J. S.
Flaherty, C.
Getty, C.
Holtze, C.
Wang, B.
Salisbury, M.
Belloli, E.
Flaherty, K. R.
Murray, S.
Xia, M.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[10] The Anti-Fibrotic Role Of Plexin C1 In Pulmonary Fibrosis
Moore, M. W.
Mathur, A.
Gan, Y.
Herzog, E.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191

← 1 2 3 4 5 →